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A B S T R A C T
Purpose: To present long-term outcome and predictors of the health related quality of life (HRQOL) in a
large group of patients operated for refractory extratemporal epilepsy.
Methods: A German QOLIE-31 questionnaire and additional questions has been mailed for all adult
patients operated for extratemporal epilepsy in the Bethel Epilepsy Centre, between 1992 and 2003, 87
patients were eligible for this study.
Results: Seizure freedom, intake of antiepileptic drugs (AEDs), presence of AEDs side effect medical
comorbidities and driving a car were signiﬁcantly correlated to HRQOL in all subscales of QOLIE-31.
Gender, age at epilepsy onset, the presence of a partner, psychiatric disease, the presence of auras and
tumour pathology have a correlation to QOL in some subscales.
Stepwise regression for all patients revealed that seizure freedom and medical comorbidities were
highly predictive for most of the subscales of QOLIE-31. Intake of anti-epileptic drugs and AED side
effects had amodest effect on QOL. The need for psychiatric treatment predicted poor cognitive function
scores. Epilepsy onset at an older age predicted aminimal increase in the overall health scores. An aura at
the last follow-up predicted poor medication scores.
Regarding the importance of the predictors, seizure freedom and medical comorbidities were the
most important predictors of QOL after surgery. AED intake and side effects had an intermediate effect on
QOL; however, the gender of the patient and age at epilepsy onset had a minimal effect on QOL.
Conclusions: HRQOL after extratemporal epilepsy surgery has multiple determinants. Medical
comorbidities should be considered a negative risk factor for QOL during preoperative and postoperative
evaluation process.
 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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The main goal of epilepsy surgery is to provide long-term
seizure freedom and improvement of health related quality of life
(HRQOL). Extratemporal epilepsy surgery has become more
effective over the years1 and a seizure-free outcome is now in
the range of 47–60% in the long-term follow-up.2
In general, studies reporting outcome after extratemporal
epilepsy surgery are rare, especially in respect of QOL. There is
only one study about extratemporal QOL, presenting short-term
outcome in a small group of patients.3 Prior studies presented the* Corresponding authors at: Klinik Mara, Maraweg 21, 33617 Bielefeld, Germany.
Tel.: +49 52177278870; fax: +49 52177278872.
E-mail addresses: alaa.elsharkawy@mara.de (A.E. Elsharkawy),
alois.ebner@mara.de (A. Ebner).
1059-1311/$ – see front matter  2009 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2009.04.010QOL after extratemporal epilepsy surgery in mixed groups with
extratemporal and temporal epilepsies.4 Despite the reports which
showed improvement ofHRQOL in short-termstudies5,6 andstudies
concerning long-term outcome beyond 5 years,7,8 outcome and
predictors for QOL after extratemporal resective epilepsy surgery as
a subgroup of the operated patients are still relatively unknown in
long-term follow-up. Our aimwas not to study the effect of surgery
on QOL. Our aim was to study the perceived quality of life in adult
patientswho underwent extratemporal epilepsy surgery and to ﬁnd
the predictors of QOL in long-term follow-up.
2. Patient data collection methods
A German version of the Quality of Life in Epilepsy-31 (QOLIE-
31) questionnaire9,10 was sent to all adult patients (16 years and
more) who had undergone extratemporal lobe (ETL) epilepsy
surgery for refractory epilepsy between 1992 and 2005 in thevier Ltd. All rights reserved.
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with mental retardation, patients with Rasmussen encephalitis
(progressive disease with special characters) as well as patients
who did not answer the questionnaire by themselves.
Of the 200 questionnaires thatwere sent out, 50 addresses (25%)
werenot correct but, among the others, 100 patients (66.7%) replied.
Weexcluded13replies (13%)becauseother familymembersﬁlled in
the questionnaire. This left 87 patients (58%) who were included in
this analysis. All questionnaires were self-administered, completed
at home, and returned by post. Furthermore, data were extracted
frompatient ﬁles regarding details of the preoperative seizure types
and frequency, presurgical investigations, surgical procedures, and
postoperative outcome at short- and long-term follow-up. Addi-
tional study-speciﬁc questions regarding seizures and auras during
the previous year, AEDs used and their side effects, employment,
driving a car, the presence of a partner and psychiatric treatment
were sent with the QOLIE-31. Demographic data, clinical character-
istics and additional data are in Table 1.
2.1. Non-responder patients
As mentioned above, there were 113 patients who did not
receive the questionnaire, did not reply or whose reply was
excluded because it was not independently given. The data of all
patients (responders, non-responders, non-independent respon-
ders) were analyzed to investigate any bias in the respondent
group. The data were similar in all three groups. Data were not
statistically different in responder and non-responder (p > 0.05),
Mann–Whitney tests and chi-square tests.
2.2. Questionnaire
2.2.1. Quality of Life in Epilepsy-31
The Quality of Life in Epilepsy-31 (QOLIE-31) is a self-
administered questionnaire. QOLIE-31 is the short form of the
QOLIE-89 and consists of 31 items.11Table 1
Summary of clinical characteristics and risk factors in 87 adult patients.
Variable Male
Demographic and epilepsy related data (years)
Mean age at seizure onset (mean  S.D.) (years) 14.1
Mean epilepsy duration 15.6
Mean age at surgery 29.9
Mean duration since surgery which QOL was measured 7.1
Mean age at reply 37.4
Site of the epileptic focus
Frontal 30 (5
Posterior cortical 24 (4
Multilobar 2 (3
Additional data
Comorbidities (total 86)
No 36 (6
Yes 19 (3
Job situation (total 87)
No 21 (3
Yes 35 (6
Psychiatric treatment (total 85)
No psychiatric treatment 46 (8
Psychiatric treatment 9 (1
Diving car (total 86)
Driving 25 (4
No driving 30 (5
Having a partner (total 87)
No 28 (5
Yes 28 (5The QOLIE-31 is an internationally used epilepsy-speciﬁc
questionnaire to self-assess quality of life. Its psychometric proper-
ties have been investigated in various studies.12 The QOLIE-31 is
made up of 7 subscales: overall quality of life, seizure worry,
emotional well-being, energy/fatigue, cognitive function, medica-
tion effects, and social function. The responses can yield seven
individual scores (one per subtest) and a total (composite) score.
2.3. Statistical analysis
ANOVAs and correlation analyses were performed to investi-
gate the effect of various factors (e.g. seizure freedom and side
effects of AED therapy) on QOLIE-31 subscales. Correlation
coefﬁcients (r, Pearson correlation coefﬁcient) or ‘Eta’ (h) were
used to describe the extent of these factors; the Eta-squared
statistics describe the proportion of variance attributable to a
factor (e.g. seizure freedom) in relation to the total variance. Eta is a
generalization of the point-biserial correlation coefﬁcient and of
the Pearson correlation coefﬁcient for the case of curvilinear
relationship. Eta is closely related to the effect size ‘f’ of the
Analysis of Variance (ANOVA) proposed by Cohen (1977). A small
(f = 0.1), medium (0.25) or large (0.5) effect size corresponds to Eta
values of 0.1, 0.24, 0.37, respectively. According to Nunnally and
Bernstein (1994), Eta values >0.3 can be regarded as ‘important’.
The relationship between the following variables and QOL was
investigated:
‘Sociodemographic’ data: age, gender, marital status (y/n),
partner* (y/n), employment*, driver’s license (y/n)*, driving a car
(y/n)*.
Epilepsy related: time since last seizure, age at onset of
epilepsy, side of operation/focus (left/right), pathology.
The relationship between QoL and time since last seizure was
analyzed using the following variables/model assumptions:
- Dichotomic model: Seizure-free since surgery (y/n)
- ‘Linear model’: time since last seizure (months).(56) Female (31) Total (87)
 12 13.5  12.3 13.9  12
 10.2 16.8  11.6 16  10.6
 11.7 30.3  12.2 30.1  11.8
 3.6 7.3  3.4 7.2  3.5
 11.4 37.2  13.2 37.3  12
3.6%) 12 (38.7%) 42 (48.3%)
2.9%) 15 (48.4%) 39 (44.8%)
.6%) 4 (12.9%) 6 (6.9%)
5.5%) 14 (45.2%) 50 (58.1%)
4.5%) 17 (54.8%) 36 (41.9%)
7.5%) 13 (41.9%) 34 (39.1%)
2.5%) 18 (58.1%) 53 (60.9%)
3.6%) 23 (76.7%) 69 (81.2%)
6.4%) 7 (23.3%) 16 (18.8%)
5.5%) 12 (38.7%) 37 (43%)
4.5%) 19 (61.3%) 49 (57%)
0%) 13 (41.9%) 41 (47.1%)
0%) 18 (58.1%) 46 (52.9%)
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seizure assuming that the impact of the last seizure on quality of
life decreases exponentially with time [exp(time since last
seizure)].
Antiepileptic drugs (AED): AEDs (y/n), side effects of AEDs
(none, mild, moderate, severe).
Co-morbidity: other diseases (y/n)*, handicapped ID (y/n)*,
psychiatric complications (psychiatric treatment/psychotherapy
during the last 12 months) (y/n)*.
Stepwise regression (forward) analyses were performed using
only those variables as predictors, which were signiﬁcantly related
with QOL and self-rated cognitive impairment. For statistical
analysis SPSS forWindows (Version 16.0, SPSS Inc., Chicago, IL)was
used.
3. Results
3.1. Seizure outcome
At the last follow-up, 45 patients (51.7%)were seizure free for at
least 1 year. From these, 27 patients (31%) had been seizure free
since surgery (best group), 42 patients (48.3%) had seizures after
surgery but achieved remission at some point during the follow-up
period, 59 patients (67.8%) were aura free and 28 patients (32.2%)
had various types of aura at the last follow-up. There was a
signiﬁcant difference between women and men (p = 0.016), with
women reporting the presence of an aura more often than men. In
the group of the 45 seizure-free patients, 6 of these (13.3%) still
experienced various types of aura.
3.2. Medication and side effects
Successful discontinuation of AEDswithout a relapse of seizures
for a minimum of 1 year prior to this study was possible for 16
patients (18.4%). Of those patients who continued taking medica-
tion, 24 patients (27.6%) were onmonotherapy, 29 patients (33.3%)
were on 2 drugs and 17 patients (19.5%) were on polytherapy.Table 2
Factors related with quality of life—Eta or Pearson correlation coefﬁcients.
Variable Overall
quality
of life
Energy/
fatigue
Well-
being
Sex .09 .18 .23*
Partner (y/n) .19 .15 .25*
Driving a car (y/n) .41*** .31** .43***
Having a job (y/n) .20 .21 .15
Age at onset .17 .20 .12
Age at surgery .03 .13 .09
Age at reply .02 .09 .04
Epilepsy duration .17 .10 .05
Duration of seizure freedom (linear) .26* .17 .16
Duration of seizure freedom (non-linear) .51** .28** .35**
Seizure free since surgery .36** .27* .33**
Presence of Aura (with or without seizures) .16 .26* .22*
AED (y/n) .39*** .23* .26*
Type of side effects of AED .44*** .32* .38**
Side effect (y/n) .43*** .31** .38***
Comorbidity .46*** .41*** .48***
Psychiatric treatment .14 .13 .10
Handicapped pass (y/n) .31** .21 .33**
Tumours .11 .09 .09
Side of surgery .12 .17 .11
FCD .12 .10 .02
Resection area .06 .15 .08
Level of signiﬁcance [***p < 0.001, **p < 0.01, *p < 0.05].Various forms of side effects were reported by 38 patients (43.7%).
Theyweremild in 17 patients (19.5%) andmoderate to severe in 21
patients (24.1%). In 25 patients (28.7%) there had been a change in
medication prior to follow-up. This change most often consisted of
AEDs being discontinued.
3.3. Comorbidities
Medical comorbidities affected 36 patients (41.9%) and
required regular treatment. Most frequent was bronchial asthma
(14%) followed by gastroenterological diseases (11%), skin diseases
(11%), as well as elevated blood pressure and orthopaedic diseases
(6%). Psychiatric and psychotherapy treatment was administered
to 18 patients (20.7%), either in hospital or in outpatient facilities.
3.4. Quality of life outcome
Univariate analysis showed that seizure freedom, intake of
antiepileptic drugs, presence of AED side effects, medical
comorbidities and driving a car were signiﬁcantly correlated to
HRQOL in all subscales of QOLIE-31. Furthermore, the presence of
an aura at the last follow-up correlated with all QOL subscales
except for cognitive function, overall quality of life and the QOLIE-
31 total score. Gender, age at epilepsy onset, the presence of a
partner, tumour pathology and psychiatric treatment had a
correlation to QOL in some subscales (Table 2).
3.5. Duration of seizure freedom
Relationships between the duration of seizure freedom and
QOL subscales were mainly non-linear. The results indicate that
QOL increase during the ﬁrst 2 years and subscales remained
stable or even decrease, however some subscales like cognitive
function energy/fatigue and well-being scores showed a greater
decrease over time than the other subscales. The total QOLIE-31
score for cases of seizure remission less than 6 months was
57.6  16. For seizure remission between 6 months and 2 years it
was 70.7  15.3, whereas for remission between 2 years and 5 yearsCognitive
function
Social
function
Seizure
worry
Medication
effects
Overall
score
health
Total
score
QOLIE-31
.02 .06 .06 .10 .12 .10
.6 .8 .11 .11 .13 .12
.29** .53*** .52*** .33** .52*** .53***
.16 .13 .15 .11 .08 .15
.03 .04 .06 .01 .25* .06
.18 .06 .12 .10 .18 .00
.21 .09 .13 .13 .13 .04
.17 .04 .06 .10 .10 .08
.01 .31** .47** .25* .40** .29*
.28** .51** .64** .42** .59** .50**
.25* .40** .45** .36** .49** .40**
.10 .24* .26* .39*** .27* .21
.31** .38** .36*** .46*** .42*** .35**
.37** .30* .45*** .46*** .25 .42**
.35** .29** .41*** .46*** .25* .41***
.38*** .39** .37** .34** .41*** .44***
.27* .08 .14 .13 .07 .10
.29** .26* .13 .15 .33** .28*
.12 .25* .09 .06 .02 .16
.04 .09 .12 .21 .10 .15
.03 .22 .12 .06 .15 .12
.11 .06 .17 .15 .15 .11
Fig. 1. QOL scores related to seizure remission duration.
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than 5 years (Fig. 1).
3.6. AEDs and AED side effects
AED intake, the occurrence of side effects due to AEDs and the
intensity of the side effects (mild, moderate or severe) were
associatedwith a lower QOL scores. The total scorewas 60.4  15.7
in patients with side effects, and 74.6  15.5 in patients who had no
side effects, but it reached 81.1  12.7 in patients who had stopped
taking AEDs.
3.7. Driving and medical comorbidities
Driving a car was correlated to all subscales of the QOL. Car-
driving patients had clearly higher QOL scores. The total score was
60.3 17 in patients who did not drive, but rose to 78.3 10.8 in
patients who did. The presence of medical comorbidities requiring
medical treatment (either as an in- or out-patient) had strong negative
effects on all QOLIE-31 subscales. Total scores here were 75.8  17 in
patientswho had nomedical comorbidities and 58.8 21.1 in patients
with one or more medical comorbidity. However driving a car was
highly correlated with duration of seizure freedom (2 years), therefore
we do not included this variable in the multivariate analysis.
3.8. Univariate analysis: factors correlated with some subscales of
QOLIE-31
Male patients had better well-being scores than females and an
older age at epilepsy onset had a positive impact on the overall
health score. Having a partner had positive effects on the well-
being subscale. Psychiatric disease requiring treatment had a
negative impact on the cognitive outcome scale of QOLIE-31.
Patients with tumour pathology had a higher social function score
than other patients.
3.9. Multivariate analysis
Predictors for the whole sample: stepwise regression for all
patients revealed that seizure freedom and medical comorbidities
were highly predictive for most of the subscales of QOLIE-31
(Table 3). The relation between the duration of seizure freedom
and QOL was mainly non-linear. Intake of AEDs and AED side
effects had a modest effect on QOL except medication effect. Theneed for psychiatric treatment predicted poor cognitive function
scores. Epilepsy onset at an older age predicted a minimal increase
in the overall health scores. An aura at the last follow-up predicted
poor medication scores (Table 3). Regarding the degree of
importance of the predictors, seizure freedom had the strongest
effect onmost of subscales predicted by seizure freedom. However,
medical comorbidities had the strongest negative effect on energy/
fatigue and well-being. Driving a car was a strong predictor for
social function. The variance inﬂation factor (VIF) showed no co-
linearity between the predictors (VIF <15).
4. Discussion
The assessment of QOL after epilepsy surgery is increasingly
recognized as an important component of clinical care and
operative outcome. The analysis shows that QOL in long-term
follow-up depends on multiple factors and predictors of QOL
varying in the degree of effect dependent mainly on the seizure
outcome and general health state.
In the whole sample, seizure freedom was the most important
predictor of the QOL even years after surgery. On the other hand, in
the best group, duration of seizure freedom had no or only a slight
prediction power. These results appear logical as the seizure
outcome determines other aspects of life after surgery. Seizure-
free patients have to undergo an adjustment process during the
transition from chronic disability to normality.13 After the seizure
outcome becomes stabilized, additional factors become decisive
for QOL. In contrast, patients who still have seizures after surgery
experience a signiﬁcant disappointment and a sense of failure.14 In
this group, seizure freedom was still the most important predictor
of QOL even years after surgery.
The secondmostpowerful factor inour studywas thepresenceof
medical comorbidities requiring medical treatment. Medical
comorbidities have a negative effect on all subscales of QOLIE-31.
Other authors have found that medical comorbid conditions were
shown to independently have a signiﬁcant contribution in predict-
ing overall QOL scores and the number of comorbid conditions was
the strongest correlate of QOL.15,16 Recent studies have documented
high rates of comorbidities among people with epilepsy compared
with healthy controls.17 The prevalence ratio of most disorders is
two- toﬁve-fold higher in adultswith epilepsy.18 The negative effect
on QOL for medical comorbidities may be due to the fact that
comorbid disorders impose a signiﬁcant burden on patients and
their families through increased efforts and expense for pharma-
ceuticals, doctor’s appointments, and in-patient hospitalization.17
Our ﬁndings conﬁrm the negative impact of medical comorbidities
on QOL. Medical comorbidities should, therefore, be considered
during preoperative evaluation and prognosis of surgery.
AEDs came in thirdwith regard to the prediction ability for QOL.
In general, AEDs are an important issue in the life of the epilepsy
patient. One of the patient’s reasons to undergo surgery is to take
fewer AEDs. Like other authors we found that AED intake and the
presence of self-reported side effects had an effect on QOL. Several
authors have also found that AEDs are one of the factors
inﬂuencing QOL.19 The negative effect of AEDs on QOL could be
due to the possible cognitive side effects of the AEDs20 or to the
negative effects on mood due to the global changes in the
excitation levels in the central nervous system.20
ThepresenceofAEDsideeffectsusuallymeansmoremedications
to treat these side effects or at least highlights the need to change or
modify theAEDs. Thismay lead to a state of uncertainty as to seizure
recurrence and constant worry about the future.
Of interest is the fact that the total scores for cognitive function
reported by patients were high in the ﬁrst 2 years after surgery and
started to decrease steadily over time. We may explain this
continual decrease in cognitive function by the fact that relapses
Table 3
Multivariate analysis (whole sample).
Predictor Overall quality
of life
Energy/fatigue Well-being Cognitive function Social function Seizure worry Medication
effects
Overall score
health
Total score
QOLIE-31
Duration of seizure
freedom (non-linear)
19.1*** [.40] (1) 26.8*** [.42] (1) 39.2*** [.64] (1) 24.0*** [.47] (1) 17.0*** [.40] (1)
AED side effects (y/n) 10.3** [.31] (2) 9.9* [.24] (2) 19.0*** [.38] (1)
Age at epilepsy onset (years) 0.4* [.18] (3)
Presence of aura (y/n) 13.9* [.26] (2)
Psychiatric treatment (y/n) 11.7* [.23] (3)
Co-morbidity (y/n) 12.2** [.32] (2) 15.4*** [.41] (1) 11.3** [.34] (1) 11.2** [.27] (1) 13.0* [.25] (2) 10.2** [.25] (2) 10.5 [.30] (2)
Sex (f/m) 7.1* [.21] (3)
Constant 78.4 61.7 77.2 77.2 89.9 94.5 85.8 78.0 78.9
VIF 2.8 2.2 3.4 2.7 2.7 2.3 2.6 4.0 2.7
n 85 83 83 81 81 82 79 81 74
R .59 .41 .57 .48 .56 .64 .53 .65 .58
R2 (corrected) .35 .17 .33 .23 .31 .41 .28 .43 .33
Seizure free since surgery (the beast group)
Duration of seizure
freedom (Linear)
1.46* [.37] (1) 1.5* [.43] (1)
Sex 18.5* [.53] (1)
Psychiatric complication .69.4* [.45] (1)
Constant 78.5 77.1. 102.86 88.9
VIF 1.8 4.8 4.8 2.9
n 26 26 26 22
R .49 .66 .50 .56
R2 .21 .40 .22 .24
For each stepwise regression the unstandardized [without brackets,] and standardized regression coefﬁcients [in parenthesis square brackets], level of signiﬁcance [***p < 0.001, **p < 0.01, *p < 0.05], order of inclusion ().
VIF = variance inﬂation factor; n = number of patients, R = multiple regression; R2 (corrected) = explained variance.
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reported that cognitive abilities are the most critical feature
associatedwith seizure control.22,23 Extratemporal surgery includes
functional areas in the frontal lobewhich have a role inmemory and
language abilities.24 Our study presents subjective data; it is a
cognitive complaint and so cognitive function may not really be
affected. We recommend an objective study for long-term outcome
of cognitive functions after extratemporal epilepsy surgery.
In our study, male gender was a predictor for better well-being
scores in the whole sample and in the best group. Generally,
differential effects of epilepsy surgery onmen compared towomen
have been studied too inconclusively. However, women experi-
ence unique epilepsy-related issues including infertility and
menstrual irregularities, complicated AED–hormone interactions,
pregnancy complications, and, in many cases, child-care respon-
sibilities.24 It has been reported that the expectations of surgery
may differ between men and women. Gender differences may also
have an impact on the surgical outcomes and QOL after surgery.
Our study conﬁrms that QOL is determined by multiple factors
and that quality of life after epilepsy surgery cannot be computed
with the basic formula ‘‘fewer seizures = better QOL.’’
4.1. Limitation of the study
Admittedlyourstudyhas limitations. TheQOLdatapresentedare
retrospective and without preoperative assessment. This study
presents patients’ subjective data and, in particular, regarding the
cognitive function, needs to be followed by objective testing.
Nevertheless, theresults inourstudyoffernewandvaluable insights.
5. Conclusion
QOL after extratemporal epilepsy surgery improved in the ﬁrst
2 years after surgery and remained relatively stable with a
tendency to decrease over time. This decreasewasmore prominent
in the cognitive function subscales. The presence of a partner,
driving a car, gender, age at epilepsy onset, psychiatric disease and
the presence of auras were correlated and associated with QOL.
However, only seizure freedom, medical comorbidities, AED
intake, the presence of side effects and the age at epilepsy onset
were found to be predictors of QOL in the multivariate analysis.
This study highlights two points. First, there is the need for more
objective studies on cognitive function after extratemporal
epilepsy surgery in long-term follow-up. The second point is that
medical comorbidities are important factors in determining the
outcome after surgery and should be considered during pre-
operative and postoperative evaluation.
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